Upgrade to SI Premium - Free Trial

Merck (MRK) Receives EU CHMP Positive Opinion for Investigational V920 Ebola Zaire Vaccine

October 18, 2019 6:45 AM
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Committee for Medicinal Products ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles